
Vivos Therapeutics (VVOS) Earnings Dates & Reports
Vivos Therapeutics (VVOS) Most Recent Earnings
Report Date
Period EndingQ3 2025
Est. EPS-$0.52
Actual EPS-$0.49
EarningsBeat
Vivos Therapeutics (VVOS) Earnings
View the latest Vivos Therapeutics (VVOS) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in Vivos Therapeutics (VVOS)
Order type
Buy in
Order amount
Est. shares
0 shares
Vivos Therapeutics (VVOS) Earnings per Share (EPS) History
Signup for full accessBrowse free
Vivos Therapeutics (VVOS) Latest Earnings
The value each VVOS share was expected to gain vs. the value each share gained.
Vivos Therapeutics (VVOS) reported its most recent earnings on for Q3 2025, posting earnings per share (EPS) of -$0.49. This exceeded analysts' expectations of -$0.52 by 5.77%, marking a Beat.
For comparison, Vivos Therapeutics reported EPS of -$0.40 in the same quarter last year.
The company is expected to announce its next earnings report on , with analysts projecting an EPS of -$0.50.
Vivos Therapeutics (VVOS) Earnings History
Vivos Therapeutics (VVOS) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the Vivos Therapeutics’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
| Report date | Price 1D before | Price 1D after | Change |
|---|---|---|---|
| — | — | — | |
| — | — | — | |
| — | — | — | |
| — | — | — |
Vivos Therapeutics (VVOS) Earnings FAQs
Vivos Therapeutics (VVOS) last reported earnings on Nov 19, 2025 for Q3 2025, posting an EPS of -$0.49, which Beat the estimate of -$0.52 by 5.77%.
For Q3 2025, Vivos Therapeutics (VVOS) reported an EPS of -$0.49, exceeding analysts' estimate of -$0.52 by 5.77%.
For Q3 2025, Vivos Therapeutics (VVOS) Beat expectations with an actual EPS of -$0.49 vs. an estimated EPS of -$0.52.
Following the last earnings report on Nov 19, 2025, Vivos Therapeutics (VVOS)'s stock price moved — from — to —.
The next Vivos Therapeutics (VVOS) earnings call is scheduled for Mar. 30, 2026, where executives will discuss financial results and outlook.